Spyre Therapeutics CFO Scott L. Burrows disposes of $1.85 million in common shares
SYRE•CFO Scott L. Burrows sold 25,000 Spyre Therapeutics shares on Sept. 30 and Oct. 1, reducing his direct stake to 79,762 shares.
1. Share sales
Burrows sold 17,500 shares on Sept. 30 at a weighted average price of $89.89. On Oct. 1, he sold 7,500 shares, including sales at weighted average prices ranging from $89.07 to $93.57.
